You are here

Goldman Sachs

Goldman Sachs closes $650M fund aimed at biotechs

Fierce Biotech

Wed, 01/3/24 - 11:08 am

‘Mea culpa’: What Goldman Sachs analysts got wrong about Medtronic in 2022

Medtech Dive

Thu, 01/5/23 - 10:02 am

Goldman Predicts ‘At Least One’ Vaccine Approval Before The End Of 2020, Raises GDP Estimate

Forbes

Wed, 08/12/20 - 10:39 am

'Burner' phones and Ariad secrets: Goldman Sachs banker pleads guilty for his role in global insider trading ring

Endpoints

Tue, 01/7/20 - 11:14 pm

insider trading

Ariad Pharmaceuticals

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials

Yahoo/Benzinga

Mon, 12/31/18 - 11:57 am

Portola Pharmaceuticals